Chordomas and chondrosarcomas involving the cavernous sinus: Review of surgical treatment and outcome in 31 patients

Giuseppe Lanzino, Laligam N. Sekhar, William L. Hirsch, Chandra N. Sen, Spiros Pomonis, Carl H. Snyderman

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

During the last 9 years, 31 patients with chordomas (20 cases) and chondrosarcomas (11 cases) involving the cavernous sinus have been treated using an aggressive surgical approach. On the basis of postoperative magnetic resonance imaging (MRI), 17 patients were considered to have undergone total removal, whereas in the remaining 14 cases the tumor was either subtotally or partially removed. Surgical complications were most commonly encountered among patients who had undergone previous operations. One patient died 3 months after the operation as a result of pulmonary embolism. Significant disability occurred in one patient because of thalamic perforator occlusion and hemorrhage. Recovery of extraocular muscle function was gratifying, and correlated to the preoperative functional level. After a median follow-up of 24 months, three recurrences (21%) occurred among the 14 patients who had undergone incomplete removal. No recurrence was observed among the 17 patients with total resection. This experience shows that gross radical removal of chordomas and chondrosarcomas involving the cavernous sinus can be accomplished with an acceptable surgical morbidity. However, much longer follow-up will be required to determine whether such aggressive surgical treatment results in cure or long-term control of these neoplasms.

Original languageEnglish (US)
Pages (from-to)359-371
Number of pages13
JournalSurgical Neurology
Volume40
Issue number5
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Chordoma
Cavernous Sinus
Chondrosarcoma
Oculomotor Muscles
Recurrence
Pulmonary Embolism
Neoplasms
Magnetic Resonance Imaging
Hemorrhage
Morbidity

Keywords

  • Cavernous sinus
  • Chondrosarcoma
  • Chordoma
  • Skull base

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Chordomas and chondrosarcomas involving the cavernous sinus : Review of surgical treatment and outcome in 31 patients. / Lanzino, Giuseppe; Sekhar, Laligam N.; Hirsch, William L.; Sen, Chandra N.; Pomonis, Spiros; Snyderman, Carl H.

In: Surgical Neurology, Vol. 40, No. 5, 1993, p. 359-371.

Research output: Contribution to journalArticle

Lanzino, Giuseppe ; Sekhar, Laligam N. ; Hirsch, William L. ; Sen, Chandra N. ; Pomonis, Spiros ; Snyderman, Carl H. / Chordomas and chondrosarcomas involving the cavernous sinus : Review of surgical treatment and outcome in 31 patients. In: Surgical Neurology. 1993 ; Vol. 40, No. 5. pp. 359-371.
@article{5b2e21efb4014e36b35faf9231a68a6a,
title = "Chordomas and chondrosarcomas involving the cavernous sinus: Review of surgical treatment and outcome in 31 patients",
abstract = "During the last 9 years, 31 patients with chordomas (20 cases) and chondrosarcomas (11 cases) involving the cavernous sinus have been treated using an aggressive surgical approach. On the basis of postoperative magnetic resonance imaging (MRI), 17 patients were considered to have undergone total removal, whereas in the remaining 14 cases the tumor was either subtotally or partially removed. Surgical complications were most commonly encountered among patients who had undergone previous operations. One patient died 3 months after the operation as a result of pulmonary embolism. Significant disability occurred in one patient because of thalamic perforator occlusion and hemorrhage. Recovery of extraocular muscle function was gratifying, and correlated to the preoperative functional level. After a median follow-up of 24 months, three recurrences (21{\%}) occurred among the 14 patients who had undergone incomplete removal. No recurrence was observed among the 17 patients with total resection. This experience shows that gross radical removal of chordomas and chondrosarcomas involving the cavernous sinus can be accomplished with an acceptable surgical morbidity. However, much longer follow-up will be required to determine whether such aggressive surgical treatment results in cure or long-term control of these neoplasms.",
keywords = "Cavernous sinus, Chondrosarcoma, Chordoma, Skull base",
author = "Giuseppe Lanzino and Sekhar, {Laligam N.} and Hirsch, {William L.} and Sen, {Chandra N.} and Spiros Pomonis and Snyderman, {Carl H.}",
year = "1993",
doi = "10.1016/0090-3019(93)90214-L",
language = "English (US)",
volume = "40",
pages = "359--371",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Chordomas and chondrosarcomas involving the cavernous sinus

T2 - Review of surgical treatment and outcome in 31 patients

AU - Lanzino, Giuseppe

AU - Sekhar, Laligam N.

AU - Hirsch, William L.

AU - Sen, Chandra N.

AU - Pomonis, Spiros

AU - Snyderman, Carl H.

PY - 1993

Y1 - 1993

N2 - During the last 9 years, 31 patients with chordomas (20 cases) and chondrosarcomas (11 cases) involving the cavernous sinus have been treated using an aggressive surgical approach. On the basis of postoperative magnetic resonance imaging (MRI), 17 patients were considered to have undergone total removal, whereas in the remaining 14 cases the tumor was either subtotally or partially removed. Surgical complications were most commonly encountered among patients who had undergone previous operations. One patient died 3 months after the operation as a result of pulmonary embolism. Significant disability occurred in one patient because of thalamic perforator occlusion and hemorrhage. Recovery of extraocular muscle function was gratifying, and correlated to the preoperative functional level. After a median follow-up of 24 months, three recurrences (21%) occurred among the 14 patients who had undergone incomplete removal. No recurrence was observed among the 17 patients with total resection. This experience shows that gross radical removal of chordomas and chondrosarcomas involving the cavernous sinus can be accomplished with an acceptable surgical morbidity. However, much longer follow-up will be required to determine whether such aggressive surgical treatment results in cure or long-term control of these neoplasms.

AB - During the last 9 years, 31 patients with chordomas (20 cases) and chondrosarcomas (11 cases) involving the cavernous sinus have been treated using an aggressive surgical approach. On the basis of postoperative magnetic resonance imaging (MRI), 17 patients were considered to have undergone total removal, whereas in the remaining 14 cases the tumor was either subtotally or partially removed. Surgical complications were most commonly encountered among patients who had undergone previous operations. One patient died 3 months after the operation as a result of pulmonary embolism. Significant disability occurred in one patient because of thalamic perforator occlusion and hemorrhage. Recovery of extraocular muscle function was gratifying, and correlated to the preoperative functional level. After a median follow-up of 24 months, three recurrences (21%) occurred among the 14 patients who had undergone incomplete removal. No recurrence was observed among the 17 patients with total resection. This experience shows that gross radical removal of chordomas and chondrosarcomas involving the cavernous sinus can be accomplished with an acceptable surgical morbidity. However, much longer follow-up will be required to determine whether such aggressive surgical treatment results in cure or long-term control of these neoplasms.

KW - Cavernous sinus

KW - Chondrosarcoma

KW - Chordoma

KW - Skull base

UR - http://www.scopus.com/inward/record.url?scp=0027496408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027496408&partnerID=8YFLogxK

U2 - 10.1016/0090-3019(93)90214-L

DO - 10.1016/0090-3019(93)90214-L

M3 - Article

C2 - 8211651

AN - SCOPUS:0027496408

VL - 40

SP - 359

EP - 371

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 5

ER -